¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦24ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­Á : 2021-08-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦24ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­Á : 2021-08-31
±³À°ÀÏÀÚ : 2021-08-31
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦24ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ
´ã´çÀÚ : ±èº¸¶ó
¿¬¶ôó : 02-508-7435  
À̸ÞÀÏ : ksbmb5@ksbmb.or.kr      
±³À°Á¾·ù : »ýÈ­ÇкÐÀÚ»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í Á¤È¸¿ø 60,000¿ø Çлýȸ¿ø 40,000¿ø ºñȸ¿øÀÏ¹Ý 80,000¿ø ºñȸ¿øÇлý 60,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ09:30~10:00 Quantification of m6A RNA modification and their gene expression regulation  ÃÖÁØÈ£(ÇѾç´ë) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ10:00~10:30 DNA methylation analysis for biomedical science  ±è¹Ì¶û(KRIBB) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ10:30~11:00 Mitochondrial RNA processing and modification  À±Á¦Çö(»ç¿ì½ºÄ³·Ñ¶óÀ̳ªÀÇ´ë) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ11:00~11:30 Functional proteogenomics: a perspective from epitranscriptomics and epigenetics  ¿ëÁ¤½Ä(¹Ì³×¼ÒŸ´ë) 
½Ä»ç 08-31  11:30~13:00 ½Ä»ç  () 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ13:00~13:30 A role of RNA modifications in mRNA stability  ±èÀ±±â(°í·Á´ë) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ13:30~14:00 Biological role of the RNA modification N6-methyladenosine in human embryonic stem cells  ±è¿ëÁØ(°æÈñ´ë) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ14:00~14:30 Deciphering the neural epitranscriptome using mouse and human brain organoid models  À±±âÁØ(KAIST) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ14:30~15:00 Aging regulation by mRNA quality control  À̽ÂÀç(KAIST) 
È޽Ġ08-31  15:00~15:20 È޽Ġ () 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ15:20~15:50 Study of circular RNAs in diverse disease models  ±è¿µ±¹(Àü³²´ë) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ15:50~16:20 Therapeutic potential of microRNAs in treating liver disease  Á¤¿µ¹Ì(ºÎ»ê´ë) 
±³À°½Ã°£ 08-31 ¿Â¶óÀΠ16:20~16:50  Studies of long noncoding RNAs in tumor-Immune microenvironment   ³²Áø¿ì(ÇѾç´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦24ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­Á : 2021-08-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ÃæûÁöȸ 9¿ù ¿ù·ÊÁý´ãȸ : 2021-09-01
´ÙÀ½±Û (¿Â¶óÀÎ) ¼Ò¾Æ¼ö¸é¿¬±¸È¸ 5Â÷ ¿Â¶óÀÎ Áý´ãȸ : 2021-08-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 8 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 3 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷